NTI 1.45% 7.0¢ neurotech international limited

Ann: Quarterly Report and Appendix 4C, page-33

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,528 Posts.
    lightbulb Created with Sketch. 89
    Someone asked a really good question about the study design of which NTI is undertaking and I thought I would also post it here:


    The NTI study tests many outcomes for children with autism - not just balance and coordination (which I might add is a real neurological consequence for children with autism. So if the mente autism neurofeedback device improves balance you know that through the changing of beta and theta waves you can conclude it is having a real neuro adaptive function in the individual user.

    Stating that, NTIs mente autism study is also measuring outcomes surrounding:

    1) Visual evoked response (eye contact)
    2) Behavioural function (improved melt down)
    3) Language skills (vocalisation)
    4) Social responsiveness scale (higher levels of sociability)
    5) Changes in the Autism behaviour checklist

    So some pretty major outcome measures!
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
0.001(1.45%)
Mkt cap ! $64.55M
Open High Low Value Volume
7.1¢ 7.1¢ 7.0¢ $16.67K 237.0K

Buyers (Bids)

No. Vol. Price($)
3 75250 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 23082 1
View Market Depth
Last trade - 14.13pm 28/11/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.